Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246028.RAeswE6yF_sUwvgTW0bl6oQoPaVAY4_13gUJ0UhFVvlE4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246028.RAeswE6yF_sUwvgTW0bl6oQoPaVAY4_13gUJ0UhFVvlE4130_assertion type Assertion NP1246028.RAeswE6yF_sUwvgTW0bl6oQoPaVAY4_13gUJ0UhFVvlE4130_head.
- NP1246028.RAeswE6yF_sUwvgTW0bl6oQoPaVAY4_13gUJ0UhFVvlE4130_assertion description "[In addition, it is worth noting that: (i) NAD incubation induced increased levels of BRCA1 in a concentration-dependent manner; (ii) Nampt knockdown-mediated reduction in NAD levels was effective at inhibiting BRCA1 expression; and (iii) the overexpression of Nampt led to higher NAD levels and a subsequent increase in BRCA1 levels in primary ovarian cancer cells and A2780, HO-8910 and ES2 ovarian cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246028.RAeswE6yF_sUwvgTW0bl6oQoPaVAY4_13gUJ0UhFVvlE4130_provenance.
- NP1246028.RAeswE6yF_sUwvgTW0bl6oQoPaVAY4_13gUJ0UhFVvlE4130_assertion evidence source_evidence_literature NP1246028.RAeswE6yF_sUwvgTW0bl6oQoPaVAY4_13gUJ0UhFVvlE4130_provenance.
- NP1246028.RAeswE6yF_sUwvgTW0bl6oQoPaVAY4_13gUJ0UhFVvlE4130_assertion SIO_000772 25486197 NP1246028.RAeswE6yF_sUwvgTW0bl6oQoPaVAY4_13gUJ0UhFVvlE4130_provenance.
- NP1246028.RAeswE6yF_sUwvgTW0bl6oQoPaVAY4_13gUJ0UhFVvlE4130_assertion wasDerivedFrom befree-2016 NP1246028.RAeswE6yF_sUwvgTW0bl6oQoPaVAY4_13gUJ0UhFVvlE4130_provenance.
- NP1246028.RAeswE6yF_sUwvgTW0bl6oQoPaVAY4_13gUJ0UhFVvlE4130_assertion wasGeneratedBy ECO_0000203 NP1246028.RAeswE6yF_sUwvgTW0bl6oQoPaVAY4_13gUJ0UhFVvlE4130_provenance.